NCT06910930 Impact of Muscle Training Device on Non-Severe OSA
| NCT ID | NCT06910930 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Thammasat University Hospital |
| Condition | OSA |
| Study Type | INTERVENTIONAL |
| Enrollment | 76 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 76 participants in total. It began in 2025-05-01 with a primary completion date of 2026-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test for the efficacy of the newly invented device #DidgeriTU with non-severe obstructive sleep apnea. The main question it aims to answer is: • Can DidgeriTU reduce apnea events in patients with non-severe obstructive sleep apnea? Researchers will compare DidgeriTU with a sham device to see how the apnea event has changed. Participants will: * Use DidgeriTU or sham device for 3 month * Do an online questionnaire once a month during the study * Home sleep test, lung function test, and tongue strength test at the start and end of the study
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with mild to moderate obstructive sleep apnea. * Age 18 years or older. * Patients voluntarily consent to provide information for research purposes. Exclusion Criteria: * Patients with an average apnea-hypopnea index (AHI) of \<4 or \>29 events per hour after repeated diagnosis using a home sleep apnea test. * Patients who refused to cease using CPAP during the study process * Patients with a history of chronic lung disease. * Elderly patients with neurological conditions that impair cognitive function, such as dementia, stroke, or psychiatric disorders. * Patients taking medications that may affect muscle function within 3 months before the start of the study. * Patients with hypothyroidism or other conditions that may affect muscle function. * Patients who consume alcohol at a moderate level or higher
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06910930 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying OSA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06910930 currently recruiting?
Yes, NCT06910930 is actively recruiting participants. Contact the research team at jazhana@gmail.com for enrollment information.
Where is the NCT06910930 trial being conducted?
This trial is being conducted at Pathum Thani, Thailand.
Who is sponsoring the NCT06910930 clinical trial?
NCT06910930 is sponsored by Thammasat University Hospital. The trial plans to enroll 76 participants.